|
Crystal Lake, Illinois, November 21, 2023 - Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, today announced the expansion of its Oncology Clinical Advisory Board. Comprised of leading clinical, oncology and digital experts from across a wide range of cancer specialties, this newly formed Clinical Advisory Board will help provide critical review and scientific guidance to Aptar Digital Health on the development of its evidence-based medical algorithms.
The new members of the Aptar Digital Health Oncology Clinical Advisory Board include:
Adam DICKER, MD, PhD – Chair and Professor of Radiation Oncology, Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA
Marilyn HUANG, MD – Professor of Gynecologic Oncology, Director of Translational Gynecologic Oncology Research, University of Miami, Miami, FL
Mario LACOUTURE, MD – Director of the Oncodermatology Program, Memorial Sloan Kettering Cancer Center, New York, NY
Aditi U. JOSHI, MD, MSc – Emergency Medicine Physician, Telehealth and Digital Health Expert, US.
These members are welcomed by existing members of the Board, including:
Paolo BOSSI, MD, Prof. – Associate Professor, Medical Oncology, University of Brescia and ASST Spedali Civili, Brescia, Italy
Karin JORDAN, MD, Prof. – Head of Department of Hematology, Oncology and Palliative Care, Ernst von Bergmann Clinic, Potsdam, Germany
Matti AAPRO, MD - Dean of Multidisciplinary Oncology Institute, Genolier Cancer Centre Switzerland
Guido CAVALETTI, MD - Head of the Neuroimmunology Center, S. Gerardo Hospital, Monza, Italy
Gregory LIP, MD - Cardio-Oncology Expertise, Liverpool Heart & Chest Hospital, Liverpool, UK.
Pere GASCON, MD, PhD - Chief of Medical Oncology and Scientific Coordinator, Hospital Clínic, Barcelona, Spain.
“We are pleased to strengthen our Clinical Advisory Board and to welcome our new members,” commented Pierre Leurent, President, Aptar Digital Health. “Their broad medical expertise will allow us to have a deeper knowledge and expand our global vision of the clinical practice for multiple types of cancer.”
Genevieve D’Orsay, MD, Chief Medical Officer at Aptar Digital Health added, “The Clinical Advisory Board contributes to the design of our clinical algorithms that support patients in the management of treatment-related symptoms. The contribution of each member is key to ensuring our solutions address a clinical need. Our Advisory Board also guides Aptar Digital Health in our clinical strategy decision, including the deployment of clinical studies.”
About Aptar Digital Health
Aptar Pharma's Digital Health division is part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar Digital Health creates end-to-end solutions to enhance patient experiences every day, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of products and solutions, Aptar Digital Health’s offering combines mobile and web apps, connected drug delivery systems, onboarding, training and advanced data analytics services to actively empower patients and create a positive treatment journey. Aptar is headquartered in Crystal Lake, Illinois and has 13,500 dedicated employees in 20 countries. For more information, please visit www.aptardigitalhealth.com and www.aptar.com.
# # #
Media Contact:
Ciara Jackson
Aptar Pharma
+49 151 1951 6502
ciara.jackson@aptar.com
|
